Group 2:Chemotherapy

4 trials

Sponsors

Shandong Provincial Cancer Hospital affiliated to Shandong University, Zhujiang Hospital of Southern Medical University, The Fifth People's Hospital of Suzhou, Shihezi University Medical School First Affiliated Hospital

Conditions

Advanced, recurrent, and persistent vaginal cancer, cervical cancer, and uterine malignanciesNon-small cell lung cancerTuberculosis

Early Phase 1

Prospective clinical study for first-generation EGFR-TKI resistance with unknown mechanism in non-small cell lung cancer: an umbrella test based on full exon sequencing

Active, not recruitingChiCTR1900021619

Zhujiang Hospital of Southern Medical UniversityNon-small cell lung cancer

Start: 2019-05-01Updated: 2019-03-04

Phase 3

A prospective, exploratory, single-center clinical study for Anlotinib Hydrochloride combined with chemotherapy versus chemotherapy alone for advanced, recurrent, and persistent vaginal cancer, cervical cancer, and uterine malignancies

Active, not recruitingChiCTR1900021190

Shandong Provincial Cancer Hospital affiliated to Shandong UniversityAdvanced, recurrent, and persistent vaginal cancer, cervical cancer, and uterine malignancies

Start: 2019-02-01Updated: 2019-02-18

Unknown Phase

Biological immunotherapy in the treatment of drug - resistant tuberculosis

Active, not recruitingChiCTR-INR-17012369

The Fifth People's Hospital of SuzhouTuberculosis

Start: 2017-09-01Updated: 2017-08-21

Metformin in patients with advanced non-small cell lung cancer chemotherapy effect and mechanism of research

Active, not recruitingChiCTR-ONN-17014156

Shihezi University Medical School First Affiliated HospitalNon-small cell lung cancer

Start: 2017-12-31Updated: 2018-01-08